MA-PRECISELY
3.11.2022 14:01:44 CET | Business Wire | Press release
Precisely, the global leader in data integrity, today announced that Devon and Cornwall Police leveraged its GIS software to enhance safety measures during the 2021 G7 Summit – the annual gathering of policy leaders from seven of the world’s major democracies. The local police force combined MapInfo Pro with third-party 3D visualizations to create a digital twin that enabled precise contingency planning – based on a model that had an accuracy of up to five millimeters.
The innovative use of geospatial solutions, alongside cutting-edge 3D technology, has huge implications for security and event planning. Mounting geopolitical tension is increasing the likelihood of security threats, meaning that high profile events, such as Queen Elizabeth II’s recent funeral procession, are requiring unprecedented levels of complex security protocol. The pandemic has also made contingency planning more challenging by limiting the ability to bring together large groups of people to do in-person planning.
“We had two major hurdles we had to cross during the planning phase for the G7 Summit,” said Robert Goldsmith, GIS and Mapping Manager, Devon and Cornwall Police. “The first challenge was managing the sheer volume of security protocols needed for such a high-profile event, particularly given that the Summit was hosted in two locations. This meant that safety measures were required for different venues, as well as for each of the world leaders, as they travelled back and forth. The second was giving visibility to our security partners around the world, especially as the pandemic limited the ability for teams to travel to the site in the run up to the event.”
The force’s GIS team quickly recognized that mapping software could play an important role to easily bring together data from a variety of sources and data formats, providing critical context in the assessment of all safety protocols leading up to and throughout the Summit. As an existing Precisely customer, Devon and Cornwall Police leveraged MapInfo Pro, a powerful desktop mapping solution that unlocks location-based context from data, empowering confident decisions grounded in visualizations of data patterns that would otherwise be hidden.
Goldsmith and his team used MapInfo Pro to generate 2D gridded map books of the venues and enriched it with points of interest (POI) data, such as foot bridges, cell masts, bus stops, and officer and partner locations. External datasets from other GIS units were also fed into the solution to seamlessly connect different formats for maximum context.
The 2D mapping created in MapInfo Pro proved to be the ideal foundation for the team to create cutting edge 3D visualizations. Leveraging capabilities provided by third-party providers, the team used aerial drone footage to build out an initial model. This was further augmented with 360-degree visualizations, using video footage that was meticulously captured by scanning over 140,000 square meters of the Summit venues.
The result was a hyper-accurate virtual representation, or digital twin, of the entire area. This enabled Devon and Cornwall Police and their partners, to anticipate security issues and create contingency plans using virtual reality headsets to remotely access locations during the planning phase. This removed the need to have more individuals on the ground than necessary in the run up to the event, while still enabling highly accurate contingency planning to take place.
“The data was accessible by our partners who could view our venues from any phone, tablet, or laptop, anywhere in the country,” said Goldsmith. “These insights benefitted a wide range of stakeholders such as our firearms, ops planning, and counter drone teams, and even external partners including the U.S. Secret Service, because they were able to understand the risks and opportunities different locations and routes presented.”
The G7 Summit went off without security hitch, with the GIS technology widely credited as being central to its success.
“Location intelligence is a crucial element of data integrity, allowing customers to unlock essential context from their data,” said Clarence Hempfield, Senior Vice President – Product Management at Precisely. “Working with Devon and Cornwall police allowed us to see our solutions in action, alongside third-party technology, to help enhance security at an internationally renowned event involving some of the world’s top leaders. We are incredibly proud to fuel organizations across the globe with the trusted data they need to confidently make critical decisions that better serve and protect their citizens.”
Learn more about how Devon and Cornwall Police used location intelligence for the G7 Summit planning here.
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221020006182/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom